Clinical trial
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
NCT07237282 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
- Lead sponsor
- University of Alberta
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- January 15, 2027
- Completion date
- January 1, 2028
- Enrollment
- 27 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.